What is Vertex Pharmaceuticals's other comprehensive income (loss), net of tax?

Vertex Pharmaceuticals (VRTX) reported other comprehensive income (loss), net of tax of -$400.00K in Q3 2025.

What does other comprehensive income (loss), net of tax mean?

Total gains or losses recorded directly to equity rather than through the income statement.

Other comprehensive income (loss), net of tax

Vertex Pharmaceuticals Other comprehensive income (loss), net of tax decreased by 102.6% to -$400.00K in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 115.4%, from $2.60M to -$400.00K. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement

SectionOther

CategoryOther

SignalHigher is better

VolatilityModerate

First reportedQ1 2016

Last reportedQ3 2025

How to read this metric

A positive trend indicates strengthening equity from non-operating sources, while a negative trend reflects headwinds like currency devaluation or investment losses.

Detailed definition

This metric encompasses all changes in equity during a period that result from transactions and other events and circums...

Peer comparison

A standard accounting line item for all public companies reporting under GAAP or IFRS.

Metric ID: is_anet_other_comprehensive_income_loss_net_of_tax

Historical Data

8 periods

	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q2 '24	Q3 '24	Q2 '25	Q3 '25
Value	$6.53M	$6.53M	$6.53M	$6.53M	-$1.20M	$2.60M	$15.30M	-$400.00K
QoQ Change	—	+0.0%	+0.0%	+0.0%	-118.4%	+316.7%	+488.5%	-102.6%
YoY Change	—	—	—	—	-118.4%	-60.2%	>999%	-115.4%

Range-$1.20M – $15.30M

CAGR-79.7%

Avg YoY Growth+270.3%

Median YoY Growth-87.8%

Frequently Asked Questions

What is Vertex Pharmaceuticals's other comprehensive income (loss), net of tax?: Vertex Pharmaceuticals (VRTX) reported other comprehensive income (loss), net of tax of -$400.00K in Q3 2025.
How has Vertex Pharmaceuticals's other comprehensive income (loss), net of tax changed year-over-year?: Vertex Pharmaceuticals's other comprehensive income (loss), net of tax decreased by 115.4% year-over-year, from $2.60M to -$400.00K.
What does other comprehensive income (loss), net of tax mean?: Total gains or losses recorded directly to equity rather than through the income statement.